Idexx Laboratories (IDXX Quick QuoteIDXX - Free Report) reported $1.14 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 14.3%. EPS of $3.47 for the same period compares to $2.96 a year ago.

The reported revenue represents a surprise of +2.1% over the Zacks Consensus Estimate of $1.12 billion. With the consensus EPS estimate being $3.42, the EPS surprise was +1.5%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Idexx performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Percent of Revenue- Gross Profit - CAG: 63.3% compared to the 61.8% average estimate based on three analysts.
• Percent of Revenue- Gross Profit - LPD: 52.1% compared to the 49.7% average estimate based on three analysts.
• Percent of Revenue- Gross Profit - Water: 72.7% versus 70% estimated by three analysts on average.
• Revenue- Companion Animal Group(CAG)- United States: $690.9 million versus $687.86 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +10.7% change.
• Revenue- Companion Animal Group(CAG)- International: $363.15 million compared to the $352.35 million average estimate based on two analysts. The reported number represents a change of +22.7% year over year.
• Revenue- LPD- International: $26.1 million versus $25.14 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +14.4% change.
• Revenue- Water- International: $23.87 million compared to the $25.48 million average estimate based on two analysts. The reported number represents a change of +9.4% year over year.
• Revenue- Companion Animal Group (CAG): $1.05 billion versus $1.03 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +14.6% change.
• Revenue- Other: $4.02 million compared to the $4.62 million average estimate based on five analysts. The reported number represents a change of -14% year over year.
• Revenue- Livestock and poultry diagnostics (LPD): $32.48 million versus $30.5 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +13.6% change.
• Revenue- Water: $50.27 million compared to the $49.27 million average estimate based on five analysts. The reported number represents a change of +10.9% year over year.
• Revenue- CAG Diagnostics capital- instruments: $42.45 million versus the three-analyst average estimate of $45.3 million. The reported number represents a year-over-year change of +32.7%.

View all Key Company Metrics for Idexx here>>>

Shares of Idexx have returned -2.5% over the past month versus the Zacks S&P 500 composite's +9.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.